Adaptive Biotechnologies Corp. (ADPT)
15.86
+0.09
(+0.57%)
USD |
NASDAQ |
Feb 09, 16:00
15.86
0.00 (0.00%)
Pre-Market: 20:00
Adaptive Biotechnologies Shareholders Equity (Quarterly) : 218.79M for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Pfizer Inc. | -- |
| Gilead Sciences, Inc. | 21.54B |
| Regeneron Pharmaceuticals, Inc. | 31.26B |
| Recursion Pharmaceuticals, Inc. | 1.047B |
| Arcellx, Inc. | 440.78M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 512.74M |
| Total Liabilities (Quarterly) | 287.74M |
| Debt to Equity Ratio | 0.9614 |
| Current Ratio | 3.338 |
| Net Debt Paydown Yield | 0.11% |